Literature DB >> 19160052

A 10-year follow-up of a longitudinal study of gallstone prevalence at necropsy in South East England.

Hamed N Khan1, Margaret Harrison, Eryl E Bassett, Tom Bates.   

Abstract

The purpose of this study was to examine a previous increase in male gallstone disease and to consider the burden of gallstones in a necropsy study with matched controls over a decade. Gallstone prevalence in 5,050 males fell from 20.2% to 19.1% (P=0.022) and in 4,125 females fell from 30.4% to 29.0% (P=0.03). Female gallstone subjects had a higher BMI than controls 24.5 vs. 23.3 (P<0.01), but males did not. Gallstones were twice as common in diabetics, but not with coronary heart disease (CHD). A third of elderly patients of both sexes had gallstones, but cholecystectomy was more common in females, 17:10%. Gallstone-related mortality was 0.7%. The prevalence of gallstones fell slightly. The association between gallstones and diabetes was confirmed, but not for CHD, and for BMI this was confined to females. Gallstones are very common in the elderly, but most are unoperated and seldom cause death. © Springer Science+Business Media, LLC 2009

Entities:  

Mesh:

Year:  2009        PMID: 19160052     DOI: 10.1007/s10620-008-0682-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

1.  Prevalence of gallstone disease in Iran.

Authors:  S Massarrat
Journal:  J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 4.029

2.  Gallstone prevalence in Christchurch: risk factors and clinical significance.

Authors:  B A Chapman; C M Frampton; I R Wilson; R J Chisholm; R B Allan; M J Burt
Journal:  N Z Med J       Date:  2000-02-25

3.  Gallstones: genetics versus environment.

Authors:  Attila Nakeeb; Anthony G Comuzzie; Lisa Martin; Gabriele E Sonnenberg; Debra Swartz-Basile; Ahmed H Kissebah; Henry A Pitt
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

Review 4.  Role of diet in cholesterol gallstone formation.

Authors:  Nahum Méndez-Sánchez; Daniel Zamora-Valdés; Norberto C Chávez-Tapia; Misael Uribe
Journal:  Clin Chim Acta       Date:  2006-09-15       Impact factor: 3.786

5.  Association between cholecystectomy and adenocarcinoma of the esophagus.

Authors:  J Freedman; W Ye; E Näslund; J Lagergren
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

Review 6.  Gallstones and gall bladder carcinoma.

Authors:  L Vitetta; A Sali; P Little; L Mrazek
Journal:  Aust N Z J Surg       Date:  2000-09

7.  Are autopsy studies reliable in assessing gallstone prevalence in the community?

Authors:  T Jørgensen; K Rossen; P Thorvaldsen
Journal:  Int J Epidemiol       Date:  1994-06       Impact factor: 7.196

8.  The relationship between cholecystectomy, unoperated gallstone disease, and colorectal cancer. A necropsy study.

Authors:  P M Mercer; F D Reid; M Harrison; T Bates
Journal:  Scand J Gastroenterol       Date:  1995-10       Impact factor: 2.423

9.  Central adiposity, regional fat distribution, and the risk of cholecystectomy in women.

Authors:  C-J Tsai; M F Leitzmann; W C Willett; E L Giovannucci
Journal:  Gut       Date:  2006-02-14       Impact factor: 23.059

10.  Prevalence of gallstone disease in relation to smoking, alcohol use, obesity, and glucose tolerance: a study of self-defense officials in Japan.

Authors:  S Kono; K Shinchi; N Ikeda; F Yanai; K Imanishi
Journal:  Am J Epidemiol       Date:  1992-10-01       Impact factor: 4.897

View more
  10 in total

1.  Natural history of acalculous biliary symptoms.

Authors:  A M Warwick; F Bintcliffe; E Wu; D Stell
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

2.  Patient outcomes after treatment with percutaneous cholecystostomy for biliary sepsis.

Authors:  S M Flexer; M B Peter; A C Durham-Hall; J R Ausobsky
Journal:  Ann R Coll Surg Engl       Date:  2014-04       Impact factor: 1.891

3.  Percutaneous Cholecystostomy for Acute Cholecystitis: A Three-Year Single-Centre Experience Including During COVID-19.

Authors:  Taner Shakir; Kabir Matwala; Abhilash Vasan; Stavros Karamanakos
Journal:  Cureus       Date:  2021-12-13

4.  Evaluation of Factors Affecting the Type of Gallstone.

Authors:  Sonay Baltacı Goktas; Manuk Manukyan; Deniz Selimen
Journal:  Indian J Surg       Date:  2015-07-12       Impact factor: 0.656

Review 5.  Epidemiology, management, and economic evaluation of screening of gallstone disease among type 2 diabetics: A systematic review.

Authors:  Lujie Chen; Yu-Ting Peng; Fu-Li Chen; Tao-Hsin Tung
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

6.  The association between gallstone disease and plaque in the abdominopelvic arteries.

Authors:  Halil İbrahim Serin; Yunus Keser Yilmaz; Yaşar Turan; Ergin Arslan; Mustafa Fatih Erkoç; Aytaç Doğan; Mehmet Celikbilek
Journal:  J Res Med Sci       Date:  2017-01-27       Impact factor: 1.852

7.  A Mitochondrial DNA Variant Elevates the Risk of Gallstone Disease by Altering Mitochondrial Function.

Authors:  Dayan Sun; Zhenmin Niu; Hong-Xiang Zheng; Fei Wu; Liuyiqi Jiang; Tian-Quan Han; Yang Wei; Jiucun Wang; Li Jin
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-12-04

8.  Association between the Dietary Inflammatory Index with gallstone disease: finding from Dena PERSIAN cohort.

Authors:  Zeinab Sadri; Javad Harouni; Farhad Vahid; Zohreh Khosravani; Fereshteh Najafi
Journal:  BMJ Open Gastroenterol       Date:  2022-09

9.  The Prevalence and Risk Factors of Gallstone Among Adults in South-East of Iran: A Population-Based Study.

Authors:  Alireza Ansari-Moghaddam; Alireza Khorram; Mahmodreza Miri-Bonjar; Mahdi Mohammadi; Hossein Ansari
Journal:  Glob J Health Sci       Date:  2015-07-30

10.  The Lowest Prevalence of Cholelithiasis in the Americas - An Autopsy-based Study.

Authors:  André Marangoni Asperti; Paulo Reis; Marcio Augusto Diniz; Mariana Dourado Pinto; Edinésio Carlos da Silva; Danilo Felipe Dias da Silva; Luiz Augusto Carneiro D'Albuquerque; Wellington Andraus
Journal:  Clinics (Sao Paulo)       Date:  2016-07       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.